News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research     6/21/2017
Bay Area Tech Titan Sean Parker Reaches Out to Unheard-Of Biotech to Confront Immunotherapy     6/20/2017
BIO2017: After IPO, Full Speed Ahead for San Diego’s Tocagen     6/20/2017
New Data Reveals This New York Biotech's Pipeline Could be a Game Changer     6/19/2017
Why Drug Giants Like Merck & Co. (MRK) and AstraZeneca PLC (AZN) Scientists are Looking in the Toilet for New Cancer Treatments     6/16/2017
Loxo Oncology (LOXO) Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It     6/8/2017
Bristol-Myers Squibb (BMY) Loses $4.3 Billion in Market Value After ASCO Update     6/8/2017
Bay Area GRAIL's Billion Gamble on the Perfect Cancer Test     6/7/2017
Unknown Nanjing Legend Emerges as a CAR-T Phenom at ASCO     6/7/2017
New Immuno-Onco Deal With Merck KGaA (MKGAF.PK) Could Make This UK Biotech a $1 Billion Company     6/6/2017
Down but Not Out, Juno (JUNO) Fights Back with Positive CAR-T Results in its JCAR017 Program     6/5/2017
Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline     6/1/2017
Kite Pharma (KITE) Stock Plunges After Report of Patient Death in CAR-T Clinical Trial     5/10/2017
3 Cancer Biotechs to Watch at ASCO     5/9/2017
Drug Giant Aspen Pharmacare Plotted to Destroy Cancer Medicine to Jack Up Prices     4/17/2017

News from Around the Web
3 Must-Covet Cancer Biotech Stocks     6/20/2017
How Upcoming Mystic Data Will Be AstraZeneca PLC (AZN) CEO's Biggest Test     6/20/2017
While Amgen (AMGN)-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines     6/19/2017
Groups Of Nanoparticles Powered By A Magnet Team Up To Kill Cancer Cells, Universidad Politécnica de Madrid Study     6/15/2017
Scientists Move Closer To Detecting Cancer Long Before Any Symptoms Appear, GRAIL Reveals     6/12/2017
These Bots Were Made For Walking, Harvard Reveals     6/9/2017
8 Things Doctors Are Buzzing About At ASCO     6/7/2017
Mark Your Calendars: Novartis AG (NVS)'s CAR-T Drug Gets A Date With The FDA Next Month     6/7/2017
A Small Drugmaker Is Taking An Entirely New Approach To Getting Its Cancer Drug Approved     6/6/2017
There's An 'Explosion Of Innovation' In New Cancer Therapies—But It Has One Big Drawback     6/2/2017
Meet The New CEO Of The Dutch Biotech Making A Cure For Blood Cancer     5/22/2017
NanoString (NSTG) Regroups After Pfizer (PFE) Walks Away From R&D Pact     5/19/2017
A Glow Stick That Detects Cancer? American Friends of Tel Aviv University Reveals     5/2/2017
Google (GOOG) AI Just Beat Human Pathologists At Detecting Cancer     4/5/2017
AbbVie (ABBV)'s New Approach To Fighting Cancer At Their Roots     3/29/2017

Press Releases
FDA Approves Genentech (RHHBY)'s RITUXAN HYCELA, A Subcutaneous Rituximab Coformulated With Halozyme ENHANZE Technology     6/23/2017
BIO2017 CARsgen Therapeutics Presented At The 2017 BIO International Convention     6/23/2017
BioWin-Cohosted Seminar At The BIO 2017 Conference Highlights Leading Cancer Immunotherapy Companies In Wallonia     6/23/2017
American Society of Hematology Release: New Antibody Uses One-Two Punch To Potentially Treat Blood Cancers     6/22/2017
TRANSGENE (ENX:TNG) Hosts Immuno-Oncology R&D Day Focused On Modulating The Tumor Micro-Environment In Paris     6/22/2017
Mithra Pharmaceuticals Completes Recruitment For Additional Estelle Safety Study     6/21/2017
Amgen (AMGN) To Present New Data At 22nd Congress Of The European Hematology Association     6/21/2017
OncoArendi Therapeutics SA Announces Selection Of Its Second Clinical Development Candidate: OATD-02 For The Treatment Of Multiple Cancers     6/21/2017
Celyad Publishes Additional Pre-Clinical Data In Support Of THINK Trial     6/21/2017
International Drug Companies Join BIO Ventures For Global Health To Tackle Cancer Crisis In Africa     6/21/2017
Leap Therapeutics Announces Collaboration With Merck & Co. (MRK) To Evaluate KEYTRUDA (Pembrolizumab) In Combination With DKN-01 In Esophagogastric Cancer     6/21/2017
Moleculin Biotech (MBRX) Announces Significant Discovery With Potential To Treat Pancreatic Cancer     6/21/2017
Helsinn Group Announces Upcoming Presentation Of Phase III Data In NEPA (Netupitant/Palonestron) At MASCC/ISOO Congress In Washington DC     6/20/2017
Galapagos (GLPG.BR)' R&D Update 2017: Rapidly Advancing Our Product Candidates     6/20/2017
Mauna Kea Technologies Release: New Publication Confirms Benefits Of Using Cellvizio For Characterizing Upper Urinary Tract Cancer     6/20/2017